Back

Absence of coronary artery disease in high-risk sickle cell anemia patients: a new illustration supporting the protective effect of Bilirubin against atherosclerosis?

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Autoimmune and chronic inflammatory disorders and heart disease (1) Autoimmune/Chronic Inflammatory Disorders and Heart Disease ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Ms Mathilde Stevenard

Montsouris Mutualist Institute, Paris (France)

7 More presentations in this session

Presentation thumbnail
Impaired right ventricular strain is associated with worse prognosis in patients with liver cirrhosis
Doctor I. Dimitroglou (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Pulmonary artery thrombosis in Behcet's syndrome: a case series
Doctor S. Chadli (Rabat, MA)
Abstract Slides Video
Presentation thumbnail
Patients vaccinated against COVID-19 present better coronary flow, myocardial work and NTproNP levels than non-vaccinated at 4 months post COVID infection.
Doctor I. Ikonomidis (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Utilization of endovascular thrombectomy in patients with antiphospholipid syndrome and acute ischemic stroke
Mr S. Pothuru (Omaha, US)
Abstract Slides Video
Presentation thumbnail
The impact of pulmonary fibrosis on cardiac function in chronic obstructive pulmonary disease
Miss K. Stolen (New Brighton, US)
Abstract Slides Video

Access the full session

Session thumbnail
Autoimmune and chronic inflammatory disorders and heart disease (1)

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Comparison of echocardiographic parameters in patients with sickle cell disease: how does recurrent transfusion therapy changes echocardiographic findings?
thumbnail
Congress Presentation
Should three dimensional right ventricular evaluation and right ventricular strain characterization have a role in the management of sickle cell disease patients?
thumbnail
Congress Presentation
Haptoglobin phenotypes and coronary artery disease: unlocking a new marker for cardiovascular risk

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources